• Skip to main content

  • Home
  • News
    • New Funds
    • New Financings
    • People On the Move
    • Trends and Strategies
  • Transactions
    • New Platforms
    • New Add Ons
    • New Exits
  • Briefly
  • 2025 Salary Survey
  • Member Center
Please enter your username/email.
Please enter your password.
Login
Something went wrong. Please check your entries and try again.
PEP-logo-v9
Flag-small-6-28-24-120x73

January 13, 2026

Private equity's news leader since 2007

Chicago, Illinois

pep-superman-header-80x105-1

"There is a right and a wrong in the universe, and that distinction is not hard to make."

Superman

  • About Us
  • Membership
  • Webinars
  • Store
  • FAQs
  • Advertise With Us
  • Contact Us
Search

label printing

Saugatuck and Ironwood Acquire Pharmaceutic Litho

October 20, 2014 by John McNulty

Saugatuck Capital and Ironwood Capital have acquired Pharmaceutic Litho & Label, a specialty printer serving  the pharmaceutical, biotech and medical device industries.

Saugatuck provided equity capital through the firm’s ninth fund, Saugatuck Capital Company IX LLC which, along with management, owns a majority interest in the company.  Ironwood Capital provided mezzanine financing as well as an equity investment.  First Niagara Bank provided the senior debt financing.

Pharmaceutic Litho & Label Company is a maker of labels, inserts & outserts, booklets, and manuals used in the pharmaceutical, biotech, and medical device industries. The company was founded in 1964 and is based near Los Angeles in Simi Valley, CA (www.pharmaceuticlitho.com).

Saugatuck Capital invests in leveraged recapitalizations, buyouts, and growth equity investments in the lower middle-market.  Saugatuck seeks companies with revenues of $15 million to $125 million in fragmented service and manufacturing industries. The firm was founded in 1982 and is based in Wilton, CT (www.saugatuckcapital.com).

“Pharmaceutic maintains a unique market niche within the printing industry and an experienced and committed management team,” said Carolyn Galiette, Senior Managing Director, Ironwood Capital.

Ironwood Capital invests from $5 million to $20 million in subordinated debt and preferred stock to support business owners and financial sponsors in growth financings, full and partial recapitalizations, generational transitions and buyouts. Target investments will have revenues from $20 million to $200 million and EBITDA from $3 million to $15 million, with margins of approximately 10% or better. The firm is industry agnostic but has specializations in recurring revenue business service models, environmental services and precision manufacturing.  The firm was formed in 1986 as a subsidiary of Aetna but was acquired from Aetna in 1991, at which time it adopted the Ironwood Capital name.  The firm has more than $500 million in capital under management and is headquartered in Avon, CT (www.ironwoodcap.com).

2014 PEPD • Private Equity’s Leading News Magazine • 10-20-14

Filed Under: New Platform, Transactions Tagged With: FS, label printing

PEP_mainlogo_White

Private Equity Professional
c/o Sun Business Media
PO Box 6610
Evanston, Illinois 60204
Office Direct (847) 920-8010

[email protected]

News

  • Platforms
  • Add Ons
  • Exits
  • Funds
  • Financings
  • People
  • Strategies

Customer Help

  • Why Advertise?
  • PEP Media Kit

Memberships

  • Individual

Advertising

  • Why Advertise?
  • PEP Media Kit

© 2026 Private Equity Professional. All Rights Reserved.